Aktuelles & Neues der Novelos Therapeutics Inc.
YM BioSciences Announces Nimotuzumab Results in Advanced Triple-Negative Breast Cancer Model Presented at AACR-NCI-EORTC Meeting
18. November 2009MISSISSAUGA, Canada – November 18, 2009 – YM BioSciences Inc. (NYSE Amex: YMI; TSX: YM), a life sciences product development company that identifies and advances a diverse portfolio of promising cancer-related products at various...
YM BioSciences Reports CYT997 Oral Vascular Disrupting Agent Results Presented at AACR-NCI-EORTC Meeting
17. November 2009MISSISSAUGA, Canada – November 17, 2009 – YM BioSciences Inc. (NYSE Amex: YMI; TSX: YM), a life sciences product development company that identifies and advances a diverse portfolio of promising cancer-related products at various...
NOVELOS THERAPEUTICS AND ACADEMIC COLLABORATORS PRESENT SCIENTIFIC FINDINGS AT INTERNATIONAL CANCER CONFERENCE
16. November 2009Anti-tumor Activities of NOV-002 in Animal and Cellular Models Highlighted
NOVELOS THERAPEUTICS CLOSES LAST TRANCHE IN $9 MILLION PRIVATE PLACEMENT
12. November 2009NEWTON, Mass., November 12, 2009 – Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that Novelos issued and sold to...
Neue Impulskraft für das BD Forum
12. November 2009Wir freuen uns das BD Forum und sein engagiertes Team als neuen Kunden bei uns begrüßen zu dürfen. Mit dem BD Forum verfügt die Region über einen hervorragenden, modernen Tagungsstandort, konzipiert für höchste architektonische...